1. P-039ToxNav germline genetic testing and PROMinet digital mobile application toxicity monitoring: results of a prospective single centre clinical utility study (PRECISE STUDY). (2nd July 2019) Authors: Lee, L; Starkey, T; Sivakumar, S; Fotheringham, S; Mozolowski, G; Shearwood, V; Palles, C; Camilleri, P; Kerr, R; Kerr, D Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P-213An evaluation of the clinical utility of a panel of variants in DPYD and ENOSF1 for predicting common capecitabine related toxicities. (20th June 2018) Authors: Palles, C; Fotheringham, S; Chegwidden, L; Lucas, M; Mozolowski, G; Tomlinson, I; Kerr, D Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗